Michael Lazarus

About Michael Lazarus

Michael Lazarus, With an exceptional h-index of 16 and a recent h-index of 15 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of Chemical Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Identification of Sugct as a modifier locus in the glutaric aciduria type 1 mouse mode

Characterization, structure and inhibition of the human succinyl-CoA: glutarate-CoA transferase, a genetic modifier of glutaric aciduria type 1

Structural insights into RNA cleavage by a novel family of bacterial RNases

A case of hyperlysinemia identified by urine newborn screening

Kinase inhibitor compounds and compositions and methods of use

Selective inhibitors of autophagy reveal new link between the cell cycle and autophagy and lead to discovery of novel synergistic drug combinations

Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1

Discovery and initial characterization of YloC, a novel endoribonuclease in Bacillus subtilis

Michael Lazarus Information

University

Position

Assistant Professor at

Citations(all)

2312

Citations(since 2020)

1235

Cited By

1579

hIndex(all)

16

hIndex(since 2020)

15

i10Index(all)

17

i10Index(since 2020)

17

Email

University Profile Page

Google Scholar

Michael Lazarus Skills & Research Interests

Chemical Biology

Top articles of Michael Lazarus

Identification of Sugct as a modifier locus in the glutaric aciduria type 1 mouse mode

Molecular Genetics and Metabolism

2024/4/1

Michael Lazarus
Michael Lazarus

H-Index: 14

Characterization, structure and inhibition of the human succinyl-CoA: glutarate-CoA transferase, a genetic modifier of glutaric aciduria type 1

bioRxiv

2024/2/7

Structural insights into RNA cleavage by a novel family of bacterial RNases

2023/12/27

A case of hyperlysinemia identified by urine newborn screening

JIMD reports

2023/11

Kinase inhibitor compounds and compositions and methods of use

2023/7/27

Selective inhibitors of autophagy reveal new link between the cell cycle and autophagy and lead to discovery of novel synergistic drug combinations

ACS chemical biology

2022/12/5

Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1

Open Biology

2022/9/21

Discovery and initial characterization of YloC, a novel endoribonuclease in Bacillus subtilis

RNA

2022/2/1

Simple secondary amines inhibit growth of gram-negative bacteria through highly selective binding to phenylalanyl-tRNA synthetase

Journal of the American Chemical Society

2021/1/7

Inhibition and crystal structure of the human DHTKD1-thiamin diphosphate complex

ACS Chemical Biology

2020/7/7

Structure–function analyses of the G729R 2-oxoadipate dehydrogenase genetic variant associated with a disorder of l-lysine metabolism

Journal of Biological Chemistry

2020/6/5

Synthesis and biological validation of a harmine-based, central nervous system (CNS)-avoidant, selective, human β-cell regenerative dual-specificity tyrosine phosphorylation …

Journal of medicinal chemistry

2020/1/31

See List of Professors in Michael Lazarus University(Icahn School of Medicine at Mount Sinai)